DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease

Grand Canyon University DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease-Step-By-Step Guide

This guide will demonstrate how to complete the Grand Canyon University DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.

How to Research and Prepare for DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease                           

Whether one passes or fails an academic assignment such as the Grand Canyon University DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.

After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.

How to Write the Introduction for DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease                         

The introduction for the Grand Canyon University DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.

How to Write the Body for DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease                         

After the introduction, move into the main part of the DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.

Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.

How to Write the Conclusion for DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease                         

After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.

How to Format the References List for DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease                           

The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.

Stuck? Let Us Help You

Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease. 

Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW. 

Sample Answer for DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease

Re: Topic 7 DQ 2

In the past two decades, the prevalence of chronic illnesses in the US has grown by a steady 7 to 8 million persons every five years. Currently, chronic illnesses affect 50% of the US population, and the treatment takes more than 85% of health care costs. The National Health Expenditure Data reveals that 90% of the country’s $4.1 trillion yearly healthcare expenditures are spent on individuals with chronic and mental health illnesses (CMS, 2018). For example, cancer is attributed to huge medical costs in the US and they are estimated to increase dramatically by 2030 due to increased cancer cases, reflecting the increasing burden of cancer care among cancer patients (Waters & Graf, 2018). In addition, heart diseases and stroke take an economic toll and cost the US health care system $216 billion annually and $147 billion in lost productivity.

Patients with chronic illnesses have a high healthcare utilization, which increases with the number of conditions one has. Individuals with multiple chronic diseases have one of the highest healthcare spending as the healthcare costs increase non-linearly with each ensuing condition (Braillard et al., 2018). Besides, multiple chronic illnesses are linked with wastage of resources due to a fragmented healthcare system. Patients often consult different medical specialists for each condition, which often leads to wastage of resources from polypharmacy, duplication of diagnostic tests, and duplication of medical procedures.

Genetics are associated with chronic illnesses like obesity, diabetes, some cancers, heart disease, and hypertension. These conditions are associated with huge costs, and more people are increasingly being diagnosed. Besides, the treatment of these genetic-related diseases significantly affects the economics of the healthcare system since patients often require life-long medication and regular follow-ups (Waters & Graf, 2018). The DNP- nurse can utilize the information to assess patients and the risk factors for chronic diseases. The nurse can educate patients on how to modify their lifestyle to eliminate the modifiable risk factors and manage the diseases in those that have been diagnosed (Waters & Graf, 2018). This can lower the healthcare costs and the wastage of health resources associated with the treatment of chronic diseases.

References

Braillard, O., Slama-Chaudhry, A., Joly, C., Perone, N., & Beran, D. (2018). The impact of chronic disease management on primary care doctors in Switzerland: a qualitative study. BMC family practice, 19(1), 159. https://doi.org/10.1186/s12875-018-0833-3

Centers for Medicare & Medicaid Services. (2018). National health expenditure data: historical. webpage, December, 16.

Waters, H. U. G. H., & Graf, M. (2018). The costs of chronic disease in the US. Santa Monica, CA: The Milken Institute.

Sample Answer 2 for DNP 810 Identify a method that uses evidence-based data to support new or innovative ways to care for patients with chronic disease

EBP, otherwise recognized as evidence-based practice, is the judicious and conscientious utilization of specialized clinical expertise alongside current best evidence and patient values to guide health care decisions. To implement evidence-based practice, practitioners must first identify practices and programs tested and shown effective (Abidi, 2017). Moreover, leaders of nursing backgrounds enact successful EBP integration through attaining generalized leadership awareness and recognizing the importance of being knowledgeable about a proposed change, partnering with a team of staff ready for the change, engaging the help of mentors or change agents at the unit level. EBP proves its indispensable nature through how it aims to provide efficacy within patient outcome improvement (Abidi, 2017). Patients expect the most effective care based on the best available evidence. It is believed that with improved healthcare delivery that focuses on evidence-based management therapies, cases of hospital readmissions can be reduced significantly (Abidi, 2017).

Hypothesis: “Healthcare professionals can implement existing evidence-based management therapies and develop strategies to prevent hospital readmission for patients diagnosed with congestive heart failure (CHF).”

According to Davidson et al. (2015), it is essential to possess standardized practice concerning congestive heart failure management. The current approach enabling doctors to embrace differing methods rooted in biased decisions does not assume a responsible stance within a modern society where advanced technology has enhanced health delivery. MAP, known as multidisciplinary action plans, are some evidence-based therapies that are increasingly becoming popular in managing congestive heart failure (Davidson et al., 2015). Designed to provide the framework for inpatient management of CHF, MAP is a structured nursing plan for inpatients. It is recommended that before a CHF patient is discharged from the hospital. A cardiologist, nephrologist, dietician, family practitioner/PCP, and a hospital representative should be present and give their approval and home health referral for medication management (Davidson et al., 2015). The primary objective is to ensure that when the patient leaves the hospital, the entire medical team will be confident that all the necessary factors are considered to minimize the chances of hospital readmissions (Davidson et al., 2015).

Doctorally prepared nurses to promote the uptake of evidence by developing the knowledge and skills of clinical nurses through role modeling, teaching, clinical problem-solving, and facilitating change (Anderson, 2015). They must be prepared to assume the responsibility and accountability to make complex health care decisions based on findings from rigorous or high-quality research reports, clinical expertise, and patient perspectives. The implementation of EBP enables DNP-prepared nurses to apply data-backed solutions that incorporate clinical expertise and current research into the decision-making process (Anderson, 2015). As a result, to produce positive patient outcomes by integrating the best research evidence, clinical expertise, and patient preferences (Anderson, 2015).

References

Abidi, S. (2017). A knowledge-modeling approach to integrate multiple clinical practice guidelines to provide evidence-based clinical decision support for managing comorbid conditions. Journal of Medical Systems, 41(12), 1-19.

Anderson, B. A. (2015). Caring for Vulnerable Populations: The Role of the DNP-Prepared Nurse. Caring for the Vulnerable: Perspectives in Nursing Theory, Practice and Research, 441.

Davidson, P. M., Newton, P. J., Tankumpuan, T., Paull, G., & Dennison-Himmelfarb, C. (2015). Multidisciplinary management of chronic heart failure: principles and future trends. Clinical therapeutics, 37(10), 2225-2233.

DNP-810 Topic 8 DQ 1 Sample Answer

Genetic technology advances have a significant clinical impact and signify that genetic testing perceptions must change. Genomic testing brings a more significant diagnostic opportunity for diagnosis alongside providing substantial predictions regarding future diagnoses. However, should therein reside an increased chance of uncertain or unexpected findings, many of which may impact multiple members of a person’s family (Zhang et al., 2015). The availability of treatment options regarding genetic technology is shifting and evolving, implicative of previously untreated disorders. Furthermore, the point of access to testing is changing with increasing provision direct to the consumer outside the formal healthcare setting (Zhang et al., 2015). 

The latest innovation in genetic engineering is the CRISPR-Cas9, the gene editing tool that allows researchers to cut DNA and paste in their chosen genetic material, creating genetically modified organisms. With other versions of CRISPR, scientists can manipulate genes in more precise ways, such as adding a new segment of DNA or editing single DNA letters (Moon et al., 2019). Scientists have also used CRISPR to detect specific targets, such as DNA from cancer-causing viruses and RNA from cancer cells. Scientists study CRISPR for many conditions, including high cholesterol, HIV, and Huntington’s disease. First and foremost, no federal legislation bans protocols or places restrictions on experiments that manipulate human DNA (Moon et al., 2019). Therefore, CRISPR is legal in the US. The FDA CRISPR regulating these trials significantly impacts diagnostics and therapeutics, allowing medicine to become more personalized (Memi et al., 2018). She said that treatments for cancer and blood disorders are furthest along because of how CRISPR is performed. “The most tested medical applications of CRISPR have been for cancer (Memi et al., 2018). 

Some of the controversial potential dangers of CRISPR include a lab experiment to fix defective DNA in human embryos, which demonstrates potential errors with genealogical editing and why leading scientists say it is too unsafe to try (Moon et al., 2019). In more than half of the cases, the editing caused unintended changes, such as the loss of an entire chromosome or big chunks (Moon et al., 2019). His adverse effects may include the double-strand DNA breaks introduced during CRISPR editing, which could result in chromothripsis, a highly damaging form of genomic rearrangement resulting from the shattering of individual chromosomes, and the subsequent rejoining of the pieces in a random order (Moon et al., 2019). With the rapid application of CRISPR/Cas in clinical research, it is essential to consider the ethical implications of such advances (Memi et al., 2018). Pertinent issues include accessibility and cost, the need for controlled clinical trials with an excellent review, and policies for compassionate use. CRISPR is an ethical game-changer essentially because it changes the debate landscape. It reduces specific ethical concerns while significantly heightening others (Memi et al., 2018). 

References 

Memi, F., Ntokou, A., & Papangeli, I. (2018, December). CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations. In Seminars in perinatology (Vol. 42, No. 8, pp. 487-500). WB Saunders. 

Moon, S. B., Kim, D. Y., Ko, J. H., & Kim, Y. S. (2019). Recent advances in the CRISPR genome editing tool set. Experimental & molecular medicine, 51(11), 1-11. 

Zhang, B., Sun, Q., & Li, H. (2015). Advances in genetic modification technologies. Sheng wu Gong Cheng xue bao= Chinese Journal of Biotechnology, 31(8), 1162-1174.